• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

One third of breast cancer survivors report pain 5-7 years after treatment

bys25qthea
April 14, 2013
in Chronic Disease, Neurology, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD/CDC.

1. In a six-year post-treatment survey, 37% of breast cancer survivors reported pain and 50% reported sensory disturbances. 

2. Women reporting pain were more likely to be ≤49 years of age and treated with axillary lymph node dissection. 

Evidence Rating Level: 2-3 (Good to Fair) 

Study Rundown: This study found a significant percentage of breast cancer survivors reported pain and sensory disturbances 5-7 years after treatment, and different subsets of women reported pain in the two- and six-year post-treatment surveys. These results support long-term pain management for survivors, particularly those who have the risk factors identified: ≤49 years old and treated with axillary lymph node dissection. Furthermore, these findings may provide another reason to follow the 2009 US Preventive Services Task Force recommendation to start routine screening at age 50 rather than 40, given estimates of breast cancer overdiagnosis and overtreatment. Strengths of this study were high response rate (89%), nationwide representativeness, and long-term follow-up (average 72.5 months), although the study design precludes claims of causation. Future investigations should collect data on pre-operative risk factors for pain, such as mental illness and socioeconomic status, and post-operative pain reports.

Click to read the study in BMJ 

Relevant Reading:  Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention

RELATED REPORTS

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer

In-Depth [repeated cross-sectional study]: The report examined persistent pain and sensory disturbances six years after breast cancer treatment in a previously studied nationwide Danish cohort of 2,828 women (ages 18-70 at treatment). Eligible participants had breast cancer surgery in 2005 or 2006 and responded to a 2008 questionnaire assessing pain and sensory disturbances (presence, location, intensity, and frequency). The 2012 questionnaire was identical to the 2008 one and filled out an average of 72.5 months post-treatment.

Of the 2,411 respondents, 37% and 50% reported pain and sensory disturbances, respectively. Changes in questionnaire responses included 15% of women reporting pain in 2012 who reported no pain in 2008, and 36% of women reporting no pain in 2012 who reported pain in 2008. Among women reporting pain in 2012, risk factors included age ≤49 years (odds ratio (OR) compared to women age ≥70: 1.78, p<0.001) and treatment with axillary lymph node dissection (OR compared to sentinel lymph node biopsy: 2.04, p<0.001).

By Caroline Huang and Leah Hawkins

More from this author: Varenicline reduces post-quit smoking relapses, Severe maternal childhood abuse associated with autism in offspring, 233 million women projected to lack modern contraceptives by 2015, Reminder intervention increases colorectal cancer screening rates, After-school program increases physical activity in overweight children, School-based therapy reduces asthma symptoms

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: Breast Cancercancer pain
Previous Post

Significant racial disparities in preterm births in infants conceived by IVF

Next Post

Quality improvement methods increase adherence to pediatric pneumonia treatment guidelines

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Chronic Disease

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

March 12, 2023
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Gastroenterology

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

March 8, 2023
#StudyGraphics: Adjuvant abemaciclib improves survival in patients  with hormone receptor-positive early breast cancer
StudyGraphics

#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer

March 8, 2023
Adjunctive TMP-SMX (Bactrim) associated with higher clinical cure rates for cutaneous abscesses
Obstetrics

Low household income associated with worse outcomes for estrogen receptor-positive breast cancer

February 28, 2023
Next Post
Quality improvement methods increase adherence to pediatric pneumonia treatment guidelines

Quality improvement methods increase adherence to pediatric pneumonia treatment guidelines

Social networks play key roles in parental vaccination decisions

Social networks play key roles in parental vaccination decisions

Incidence of pediatric melanoma is increasing

Incidence of pediatric melanoma is increasing

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Synergistic interaction between risk burden and genetics for atrial fibrillation development
  • Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma
  • Specific histopathologic renal lesions may be associated with increased risk of cardiovascular disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options